THE CHOSUNILBO on MSN10h
Korean pharma accelerates FDA efforts, betting on regulatory shiftsYuhan Corp. posted record-breaking third-quarter results, with revenue reaching 598.8 billion won and operating profit ...
We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.
DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...
Appointed Douglas Williams, Ph.D. as Chair of the Board of DirectorsFDA Clearance of Investigational New Drug Application (IND) for systemic ...
Department of Physiology, Harold Hamm Diabetes Center, The University of Oklahoma Health Science Center, Oklahoma City, United States ...
Zizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.
Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant ...
This year, TechCrunch Disrupt 2024 showcased the incredible talent and groundbreaking ideas of our 2024 Startup Battlefield ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback